(Q40899008)

24 September 2017

1 reference

title

PET in oncology: will it replace the other modalities? (English)

1 reference

24 September 2017

Hoh CK

1

1 reference

24 September 2017

Schiepers C

2

1 reference

24 September 2017

Seltzer MA

3

1 reference

24 September 2017

Gambhir SS

4

1 reference

24 September 2017

Silverman DH

5

1 reference

24 September 2017

Czernin J

6

1 reference

24 September 2017

Maddahi J

7

1 reference

24 September 2017

Phelps ME

8

1 reference

24 September 2017

1 April 1997

1 reference

Seminars in Nuclear Medicine

24 September 2017

1 reference

24 September 2017

27

1 reference

24 September 2017

2

1 reference

24 September 2017

94-106

1 reference

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

On the Origin of Cancer Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Positron emission tomography of thyroid masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Glucose utilization in vivo by human pulmonary neoplasms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Satellite PET and lung cancer: a prospective study in surgical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Recurrence of colorectal tumors: PET evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

The solitary pulmonary nodule. Decision analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

FDG-PET evaluation of indeterminate pancreatic masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Whole body skeletal imaging with [18F]fluoride ion and PET

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Mediastinal staging of non-small-cell lung cancer with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Experience with positron emission tomography (PET) scans in patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2897%2980042-6

10.1016/S0001-2998(97)80042-6

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference